About the Experimental and Translational Ophthalmology Session
Experimental and Translational Ophthalmology connects fundamental discoveries in ocular biology with the development of new diagnostic and therapeutic approaches. The session encompasses experimental disease models, cellular and molecular mechanisms, preclinical studies, therapeutic targets, translational research, and pathways that move discoveries from laboratory investigation toward clinical application.
Abstract Scope and Participation
Submissions may include basic science, cellular and molecular studies, experimental models, preclinical research, therapeutic development, translational methods, and proof-of-concept investigators. Basic scientists, ophthalmologists, biomedical researchers, translational investigators, pharmacologists, and interdisciplinary research teams are invited to participate.
Topics Covered in Experimental and Translational Ophthalmology
Topic 01
Disease Models
Topic 02
Molecular Research
Topic 03
Cellular Research
Topic 04
Translational Studies
Topic 05
Disease Mechanisms
Topic 06
Therapeutic Targets
Featured Speakers — Experimental and Translational Ophthalmology 2027
Recent Research Presented at Experimental and Translational Ophthalmology Sessions
Advanced 3D human-based in vitro models to identify glaucoma-specific molecular markers and to study the pathological crosstalk leading to neuroinflammation
Retinal cell death is a common pathological hallmark of several neurodegenerative diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration. Among these, Primary…
Amyloid associated protein misfolding and structural alterations in human cataractous lenses
Cataract, opacification of the lens, is a multifactorial eye disease affecting millions of people globally. However, its underlying etiology remains unclear despite progress in surgical methods.…
Hydrogen rich saline treatment modulates proteomic profiles to mitigate cataract development in an N methyl N nitrosourea induced rat model
Purpose: Cataracts are associated with oxidative stress-induced damage to lens proteins. This study aims to identify Differentially Expressed Proteins (DEPs) associated with the protective effects of…
An advanced 3D human based in vitro model to identify disease specific molecular markers of glaucoma neurodegeneration
Several neurodegenerative diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration all involve retinal cell death. Reliable experimental models of such diseases are…
Preclinical evaluation of optogenetic therapy by clinically relevant multi-luminance behavioral test
Optogenetic therapy holds great potential for treatment of late-stage photoreceptor degenerative diseases. However, clinical translation of such therapeutic candidates is usually impeded by…
Inhibitory effects of novel artemisinin derivative on laser-induced choroidal neovascularization via regulating AKT and ERK1/2 pathways
Choroidal neovascularization (CNV) is a major cause of blindness in ocular fundus disease. The major defects of the current first-line anti-VEGF drugs for fundus disease are the high administration…
Related Scientific Sessions at IOC 2027
Why Attend the Experimental and Translational Ophthalmology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Experimental and Translational Ophthalmology work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Experimental and Translational Ophthalmology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Experimental and Translational Ophthalmology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Experimental and Translational Ophthalmology Conference 2027 — FAQs
What is the Experimental and Translational Ophthalmology track at IOC 2027?
The Experimental and Translational Ophthalmology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Experimental and Translational Ophthalmology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Experimental and Translational Ophthalmology sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Experimental and Translational Ophthalmology are all welcome — whether presenting or attending.
Can I present my research in the Experimental and Translational Ophthalmology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Experimental and Translational Ophthalmology sessions?
Yes. IOC 2027 is a hybrid conference — attend the Experimental and Translational Ophthalmology track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.